Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Standaert

Showing results (121-130 of 188) with videos related to

Pageof 19
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 28, 2009
Dysregulation of CalDAG-GEFI and CalDAG-GEFII predicts the severity of motor side-effects induced by anti-parkinsonian therapyJill R Crittenden, Ippolita Cantuti-Castelvetri, Esen Saka, et al.
Movement Disorders Clinical Practice|December 16, 2017
Effect of Levodopa-carbidopa Intestinal Gel on Non-motor Symptoms in Patients with Advanced Parkinson's DiseaseDavid G Standaert, Ramon L Rodriguez, John T Slevin, et al.
Neurobiology of Disease|March 1, 2003
TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletionKevin Rostasy, Sarah J Augood, Jeffrey W Hewett, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 5, 2024
Basic Science in Movement Disorders: Fueling the Engine of Translation into Clinical PracticeTiago F Outeiro, Lorraine V Kalia, Erwan Bezard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 5, 2022
RORγt-Expressing Pathogenic CD4<sup>+</sup> T Cells Cause Brain Inflammation during Chronic ColitisMichel Edwar Mickael, Suniti Bhaumik, Ayanabha Chakraborti, et al.
Parkinsonism & Related Disorders|January 5, 2013
Levodopa-carbidopa intestinal gel in advanced Parkinson's disease open-label study: interim resultsHubert H Fernandez, Arvydas Vanagunas, Per Odin, et al.
Parkinsonism & Related Disorders|December 24, 2016
Understanding falls in progressive supranuclear palsyBrent Bluett, Irene Litvan, Shumin Cheng, et al.
Journal of Neurochemistry|January 24, 2007
Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigraJessie L St Martin, Jochen Klucken, Tiago F Outeiro, et al.
Journal of Neurochemistry|April 16, 2008
Striatal histone modifications in models of levodopa-induced dyskinesiaAnthony P Nicholas, Farah D Lubin, Penelope J Hallett, et al.
Neurobiology of Disease|December 15, 2019
Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded α-synuclein inclusionsLindsay E Stoyka, Andrew E Arrant, Drake R Thrasher, et al.
Pageof 19

Showing results (121-130 of 188) with videos related to

Sort By:
Pageof 19
Proceedings of the National Academy of Sciences of the United States of America|January 28, 2009
Dysregulation of CalDAG-GEFI and CalDAG-GEFII predicts the severity of motor side-effects induced by anti-parkinsonian therapyJill R Crittenden, Ippolita Cantuti-Castelvetri, Esen Saka, et al.
Movement Disorders Clinical Practice|December 16, 2017
Effect of Levodopa-carbidopa Intestinal Gel on Non-motor Symptoms in Patients with Advanced Parkinson's DiseaseDavid G Standaert, Ramon L Rodriguez, John T Slevin, et al.
Neurobiology of Disease|March 1, 2003
TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletionKevin Rostasy, Sarah J Augood, Jeffrey W Hewett, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 5, 2024
Basic Science in Movement Disorders: Fueling the Engine of Translation into Clinical PracticeTiago F Outeiro, Lorraine V Kalia, Erwan Bezard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 5, 2022
RORγt-Expressing Pathogenic CD4<sup>+</sup> T Cells Cause Brain Inflammation during Chronic ColitisMichel Edwar Mickael, Suniti Bhaumik, Ayanabha Chakraborti, et al.
Parkinsonism & Related Disorders|January 5, 2013
Levodopa-carbidopa intestinal gel in advanced Parkinson's disease open-label study: interim resultsHubert H Fernandez, Arvydas Vanagunas, Per Odin, et al.
Parkinsonism & Related Disorders|December 24, 2016
Understanding falls in progressive supranuclear palsyBrent Bluett, Irene Litvan, Shumin Cheng, et al.
Journal of Neurochemistry|January 24, 2007
Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigraJessie L St Martin, Jochen Klucken, Tiago F Outeiro, et al.
Journal of Neurochemistry|April 16, 2008
Striatal histone modifications in models of levodopa-induced dyskinesiaAnthony P Nicholas, Farah D Lubin, Penelope J Hallett, et al.
Neurobiology of Disease|December 15, 2019
Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded α-synuclein inclusionsLindsay E Stoyka, Andrew E Arrant, Drake R Thrasher, et al.
Pageof 19